Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Licorice + lotus root powder is an investigational herbal combination therapy being developed by the Second Affiliated Hospital, School of Medicine, Zhejiang University for the treatment of *Helicobacter pylori* infection. The regimen utilizes licorice (*Glycyrrhiza glabra*), a traditional Chinese medicine that has demonstrated anti-*H. pylori* activity in both in vitro and animal studies, combined with lotus root powder. In clinical trial settings (e.g., NCT06881524), this combination is administered as an adjunct to a dual-therapy regimen consisting of vonoprazan (a potassium-competitive acid blocker) and low-dose amoxicillin. The primary goal of incorporating these natural products is to enhance the eradication rate of *H. pylori* while reducing the necessity for high-dose antibiotics, thereby mitigating associated adverse effects such as nephrotoxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on licorice + lotus root powder.